The following first appeared in the Substack of Eric Topol, MD, called Ground Truths. In recent days, there were several important new reports that help explain the […]
Pepaxto Update [2/23/2024] Today, FDA announced its final decision to withdraw approval of Pepaxto (melphalan flufenamide), which was approved for use in combination with dexamethasone to treat […]
The European Medicines Agency gave marketing authorization to two cancer therapies in February. Non–Small Cell Lung Cancer The Committee for Medicinal Products for Human Use (CHMP) approved tislelizumab (Tizveni) […]
UPDATE: On February 23, 2024, the FDA announced its final decision to withdraw approval of melphalan flufenamide (Pepaxto) with dexamethasone to treat certain patients with multiple myeloma. […]
In its February 2024 meeting, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use has granted marketing authorizations for Pyzchiva (ustekinumab) for the […]
1/29/2024 FDA revises letter of authorization for the emergency use authorization for Paxlovid 1/23/2024 FDA’s ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital […]
Two treatments for rare genetic diseases have been granted approval this month by the European Medicines Agency (EMA). Amyotrophic Lateral Sclerosis The agency recommended granting a marketing authorization […]
The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of two vaccines for active immunization against the H5N1 […]
A group of 16 Democratic legislators on the House Committee on Oversight and Reform has demanded in a letter that the drugmaker Pfizer present details on […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.